Mind the gap: anti–PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma

Key Points

• The research aims to evaluate the efficacy of anti-PD-1 therapy prior to autologous transplantation in Hodgkin lymphoma.
• Pilot clinical trial assessing anti-PD-1 treatment efficacy.
• Participants with classical Hodgkin lymphoma were chosen for treatment study.
• Outcomes were compared before and after autologous transplantation.
• Demonstrated improved response rates with anti-PD-1 salvage therapy before transplantation.
• Potential enhancement of long-term outcomes in patients with classical Hodgkin lymphoma.